Key Objective
Initial public offering of 4,616,804 equity shares of face value of Rs. 10 each ("equity shares") of Tatva Chintan Pharma Chem Limited ("the company" or the "issuer") for cash at a price of Rs. 1,083 per equity share (including a premium of Rs. 1,073 per equity share) ("offer price" aggregating to Rs. 500 Crores. The offer comprises of a fresh issue of 2,077,562 equity shares aggregating to Rs. 225 Crores ("fresh issue") and an offer for sale of 2,539,242 equity shares aggregating to Rs. 275 Crores, comprising 215,143 equity shares aggregating to Rs. 23.30 Crores by Ajaykumar Mansukhlal Patel, 751,616 equity shares aggregating to Rs. 81.40 Crores by Chintan Nitinkumar Shah, and 674,054 equity shares aggregating to Rs. 73 Crores by Shekhar Rasiklal Somani (collectively the "promoter selling shareholders") and 95,106 equity shares aggregating to Rs. 10.30 Crores by Darshana Nitinkumar Shah, 315,789 equity shares aggregating to Rs. 34.20 Crores by Priti Ajaykumar Patel, 315,789 equity shares aggregating to Rs. 34.20 Crores by Ajay Mansukhlal Patel Huf, 101,570 equity shares aggregating to Rs. 11 Crores by Kajal Shekhar Somani, 10,157 equity shares aggregating to Rs. 1.10 Crores by Shitalkumar Rasiklal Somani, and 60,018 equity shares aggregating to Rs. 6.50 Crores by Samirkumar Rasiklal Somani (collectively The "promoter group selling shareholders", and together with the promoter selling shareholders, the "selling shareholders") (the "offer for sale", and together with the fresh issue, the "offer"). The offer constitutes 20.83% of the post-offer paid-up equity share capital.
Offer Price : Rs. 1083 per equity shares of face value of Rs. 10 Each.
Anchor Investor offer price : Rs. 1083 per equity share.
The offer price is 108.3 times the face value.